{
    "xml": "<topic id=\"PHP4695\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/strontium-ranelate\" basename=\"strontium-ranelate\" title=\"STRONTIUM RANELATE\">\n<title>STRONTIUM RANELATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1026\" namespace=\"/interactions/list-of-drug-interactions/strontium-ranelate\">Strontium Ranelate</xref>\n</p>\n<data name=\"vtmid\">441487000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_738628171\" title=\"Bone formation stimulants\">Bone formation stimulants</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP73185\" outputclass=\"drugAction\" rev=\"1.8\" parent=\"/drugs/strontium-ranelate\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Stimulates bone formation and reduces bone resorption.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73166\" outputclass=\"indicationsAndDose\" rev=\"1.17\" parent=\"/drugs/strontium-ranelate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of severe osteoporosis in postmenopausal women or men at high risk of fracture for whom other treatments are contra-indicated or not tolerated (initiated under specialist supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8239;g once daily, dose to be taken in water, preferably at bedtime.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73191\" outputclass=\"contraindications\" rev=\"1.6\" parent=\"/drugs/strontium-ranelate\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Cerebrovascular disease</ph>; <ph outputclass=\"contraindication\">current or previous venous thromboembolic event</ph>; <ph outputclass=\"contraindication\">ischaemic heart disease</ph>; <ph outputclass=\"contraindication\">peripheral arterial disease</ph>; <ph outputclass=\"contraindication\">temporary or prolonged immobilisation</ph>; <ph outputclass=\"contraindication\">uncontrolled hypertension</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73197\" outputclass=\"cautions\" rev=\"1.9\" parent=\"/drugs/strontium-ranelate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Predisposition to cardiovascular disease&#8212;assess risk before and every 6&#8211;12 months during treatment</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73162\" outputclass=\"interactions\" rev=\"1.6\" parent=\"/drugs/strontium-ranelate\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (strontium ranelate).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73140\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/strontium-ranelate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dermatitis</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">eczema</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">myocardial infarction</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">venous thromboembolism</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Angioedema</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">alopecia</ph>; <ph outputclass=\"sideEffect\">bone marrow suppression</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>; <ph outputclass=\"sideEffect\">gastro-oesophageal reflux</ph>; <ph outputclass=\"sideEffect\">peripheral oedema</ph>; <ph outputclass=\"sideEffect\">stomatitis</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Severe allergic reactions</p>\n<p>Severe allergic reactions, including drug rash with eosinophilia and systemic symptoms (DRESS), have been reported in patients taking strontium ranelate. DRESS starts with rash, fever, swollen glands, and increased white cell count, and it can affect the liver, kidneys and lungs; DRESS can also be fatal. Treatment with strontium ranelate should not be restarted.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73153\" outputclass=\"renalImpairment\" parent=\"/drugs/strontium-ranelate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73107\" outputclass=\"effectOnLaboratoryTests\" rev=\"1.6\" parent=\"/drugs/strontium-ranelate\">\n<title>Effect on laboratory tests</title>\n<body>\n<section>\n<sectiondiv>\n<p>Interferes with colorimetric measurements of calcium in blood and urine.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73204\" outputclass=\"directionsForAdministration\" rev=\"1.11\" parent=\"/drugs/strontium-ranelate\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Avoid food for 2 hours before and after taking granules, particularly calcium-containing products e.g. milk; also preferably avoid concomitant antacids containing aluminium and magnesium hydroxides for 2 hours after taking granules.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73155\" outputclass=\"patientAndCarerAdvice\" rev=\"1.12\" parent=\"/drugs/strontium-ranelate\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p outputclass=\"title\">Severe allergic reactions</p>\n<p>Patients should be advised to stop taking strontium ranelate and consult their doctor immediately if skin rash develops.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer strontium ranelate granules.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73104\" outputclass=\"nationalFunding\" rev=\"1.35\" parent=\"/drugs/strontium-ranelate\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA160</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p>\r\n<p>\r\n<b>Strontium ranelate</b> is recommended as an alternative for women:</p>\r\n<ul>\r\n<li>in whom alendronate and risedronate are contra-indicated or not tolerated <b>and</b>\r\n</li>\r\n<li>who comply with particular combinations of bone mineral density measurement, age, and independent risk factors for fracture, as indicated in the full NICE guidance.</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA160\">www.nice.org.uk/TA160</xref>\n</sectiondiv>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA161</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p>\r\n<p>This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture.</p>\r\n<p>\r\n<b>Strontium ranelate</b> is recommended as an alternative for women:</p>\r\n<ul>\r\n<li>in whom alendronate and risedronate are contra-indicated or not tolerated <b>and</b>\r\n</li>\r\n<li>who comply with particular combinations of bone mineral density measurement, age, and independent risk factors for fracture, as indicated in the full NICE guidance.</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA161\">www.nice.org.uk/TA161</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP4695-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/strontium-ranelate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74879\" title=\"Granules\" namespace=\"/drugs/strontium-ranelate/granules\">Granules</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107735\" namespace=\"/guidance/prescribing-in-palliative-care\" title=\"Prescribing in palliative care\" count=\"1\" rel=\"backlink\">Prescribing in palliative care</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78591\" namespace=\"/treatment-summaries/hormones-malignant-disease\" title=\"Hormones, malignant disease\" count=\"1\" rel=\"backlink\">Hormones, malignant disease</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1026\" namespace=\"/interactions/list-of-drug-interactions/strontium-ranelate\" title=\"Strontium Ranelate\" count=\"1\" rel=\"link\">Strontium Ranelate</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74879\" namespace=\"/drugs/strontium-ranelate/granules\" title=\"Granules\" count=\"1\" rel=\"link\">Granules</xref>\n</links>\n</topic>",
    "id": "PHP4695",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/strontium-ranelate",
    "basename": "strontium-ranelate",
    "title": "STRONTIUM RANELATE",
    "interactants": [
        {
            "id": "bnf_int_1026",
            "label": "Strontium Ranelate"
        }
    ],
    "vtmid": "441487000",
    "drugClassification": [
        "Bone formation stimulants"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Stimulates bone formation and reduces bone resorption.",
                "html": "<p>Stimulates bone formation and reduces bone resorption.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of severe osteoporosis in postmenopausal women or men at high risk of fracture for whom other treatments are contra-indicated or not tolerated (initiated under specialist supervision)",
                        "html": "Treatment of severe osteoporosis in postmenopausal women or men at high risk of fracture for whom other treatments are contra-indicated or not tolerated (initiated under specialist supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "2 g once daily, dose to be taken in water, preferably at bedtime.",
                        "html": "<p>2&#8239;g once daily, dose to be taken in water, preferably at bedtime.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Cerebrovascular disease",
                "html": "Cerebrovascular disease"
            },
            {
                "type": "contraindications",
                "textContent": "current or previous venous thromboembolic event",
                "html": "current or previous venous thromboembolic event"
            },
            {
                "type": "contraindications",
                "textContent": "ischaemic heart disease",
                "html": "ischaemic heart disease"
            },
            {
                "type": "contraindications",
                "textContent": "peripheral arterial disease",
                "html": "peripheral arterial disease"
            },
            {
                "type": "contraindications",
                "textContent": "temporary or prolonged immobilisation",
                "html": "temporary or prolonged immobilisation"
            },
            {
                "type": "contraindications",
                "textContent": "uncontrolled hypertension",
                "html": "uncontrolled hypertension"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Predisposition to cardiovascular disease&#8212;assess risk before and every 6&#8211;12 months during treatment",
                "html": "Predisposition to cardiovascular disease&#8212;assess risk before and every 6&#8211;12 months during treatment"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (strontium ranelate).",
                "html": "<p>Appendix 1 (strontium ranelate).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Dermatitis",
                        "html": "Dermatitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "eczema",
                        "html": "eczema",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "myocardial infarction",
                        "html": "myocardial infarction",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "venous thromboembolism",
                        "html": "venous thromboembolism",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Angioedema",
                        "html": "Angioedema",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "alopecia",
                        "html": "alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bone marrow suppression",
                        "html": "bone marrow suppression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "constipation",
                        "html": "constipation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-oesophageal reflux",
                        "html": "gastro-oesophageal reflux",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "peripheral oedema",
                        "html": "peripheral oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "stomatitis",
                        "html": "stomatitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Severe allergic reactions",
                "textContent": "Severe allergic reactions, including drug rash with eosinophilia and systemic symptoms (DRESS), have been reported in patients taking strontium ranelate. DRESS starts with rash, fever, swollen glands, and increased white cell count, and it can affect the liver, kidneys and lungs; DRESS can also be fatal. Treatment with strontium ranelate should not be restarted.",
                "html": "<p>Severe allergic reactions, including drug rash with eosinophilia and systemic symptoms (DRESS), have been reported in patients taking strontium ranelate. DRESS starts with rash, fever, swollen glands, and increased white cell count, and it can affect the liver, kidneys and lungs; DRESS can also be fatal. Treatment with strontium ranelate should not be restarted.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "effectOnLaboratoryTests": {
        "effectOnLaboratoryTests": [
            {
                "type": "effectOnLaboratoryTests",
                "textContent": "Interferes with colorimetric measurements of calcium in blood and urine.",
                "html": "<p>Interferes with colorimetric measurements of calcium in blood and urine.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Avoid food for 2 hours before and after taking granules, particularly calcium-containing products e.g. milk; also preferably avoid concomitant antacids containing aluminium and magnesium hydroxides for 2 hours after taking granules.",
                "html": "<p>Avoid food for 2 hours before and after taking granules, particularly calcium-containing products e.g. milk; also preferably avoid concomitant antacids containing aluminium and magnesium hydroxides for 2 hours after taking granules.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "title": "Severe allergic reactions",
                "textContent": "Patients should be advised to stop taking strontium ranelate and consult their doctor immediately if skin rash develops.",
                "html": "<p>Patients should be advised to stop taking strontium ranelate and consult their doctor immediately if skin rash develops.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer strontium ranelate granules.",
                "html": "<p>Patients or carers should be given advice on how to administer strontium ranelate granules.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA160",
                        "label": "www.nice.org.uk/TA160"
                    }
                ],
                "fundingIdentifier": "NICE TA160",
                "textContent": "Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008) Strontium ranelate is recommended as an alternative for women: in whom alendronate and risedronate are contra-indicated or not tolerated and who comply with particular combinations of bone mineral density measurement, age, and independent risk factors for fracture, as indicated in the full NICE guidance.\n\nwww.nice.org.uk/TA160",
                "html": "<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p> <p> <b>Strontium ranelate</b> is recommended as an alternative for women:</p> <ul> <li>in whom alendronate and risedronate are contra-indicated or not tolerated <b>and</b> </li> <li>who comply with particular combinations of bone mineral density measurement, age, and independent risk factors for fracture, as indicated in the full NICE guidance.</li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA160\">www.nice.org.uk/TA160</xref>"
            },
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA161",
                        "label": "www.nice.org.uk/TA161"
                    }
                ],
                "fundingIdentifier": "NICE TA161",
                "textContent": "Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008) This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture. Strontium ranelate is recommended as an alternative for women: in whom alendronate and risedronate are contra-indicated or not tolerated and who comply with particular combinations of bone mineral density measurement, age, and independent risk factors for fracture, as indicated in the full NICE guidance.\n\nwww.nice.org.uk/TA161",
                "html": "<p outputclass=\"title\">Alendronate, etidronate, risedronate, raloxifene, strontium ranelate, and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (October 2008)</p> <p>This guideline recommends treatment options for the secondary prevention of osteoporotic fractures in postmenopausal women with confirmed osteoporosis who have also sustained a clinically apparent osteoporotic fracture.</p> <p> <b>Strontium ranelate</b> is recommended as an alternative for women:</p> <ul> <li>in whom alendronate and risedronate are contra-indicated or not tolerated <b>and</b> </li> <li>who comply with particular combinations of bone mineral density measurement, age, and independent risk factors for fracture, as indicated in the full NICE guidance.</li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA161\">www.nice.org.uk/TA161</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74879",
                "label": "Granules",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP107735",
                "label": "Prescribing in palliative care",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78591",
                "label": "Hormones, malignant disease",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1026",
                "label": "Strontium Ranelate",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74879",
                "label": "Granules",
                "type": "medicinalForm"
            }
        ]
    }
}